Healthcare Contract Development And Manufacturing Organization Market 2020 and Forecast 2021-2027

                                          
Report Overview: Healthcare Contract Development And Manufacturing Organization Market


The global healthcare contract development and manufacturing organization market size was estimated at 182.3 billion in 2020 and is anticipated to expand at a CAGR of 7.9% over the forecast period 2021-2027. Increasing outsourcing of R&D is one of the major factors contributing to market growth. Healthcare contract development and manufacturing organization (CDMO) provides outsourcing services to various pharmaceutical industries on a contract basis. Increase in the outsourcing by pharmaceutical companies, growing pharmaceutical industry, and support of CDMOs in reducing the operational and capital expenses are some of the major factors anticipated to propel the market growth.

Healthcare contract development and manufacturing organizations offer one-stop solutions from development to manufacturing to all the pharmaceutical and medical device companies on a contract basis. Most of the small-sized pharmaceutical and biopharmaceutical companies prefer outsourcing their development and manufacturing organization activities due to lack of internal capabilities.
In addition, favorable regulatory affairs in developing economies and assurance of quality services are other major drivers for contract development and manufacturing organization market. Most of the pharmaceutical and biopharmaceutical companies are outsourcing their manufacturing activities to CDMOs in order to meet the rising demand for small molecules and biologics in emerging countries. This is expected to drive market growth over the forecast period.

However, increasing logistic costs, serialization issues faced by healthcare organizations, and threat of infringement of Intellectual Property (IP) rights are anticipated to restrain the market growth for healthcare contract development and manufacturing organization over the forecast period.

Services Insights: Healthcare Contract Development And Manufacturing Organization Market

The market is segmented on the basis of services, which includes contract development and contract manufacturing. The contract manufacturing segment accounts for the largest market share of 72.7 % in 2019 and is also expected to grow at the fastest CAGR of 8.1 % during the forecast period. Growing trend of outsourcing, increasing use of medical devices due to the rising prevalence of various chronic diseases, and complexity in manufacturing devices are expected to drive the healthcare contract development and manufacturing organization market.

Contract manufacturing is further sub-segmented into API/bulk drugs, finished dose formulations, and medical device. In the contract manufacturing segment, the medical device is expected to account for the largest market share of 47.5% in 2019. The medical device segment is further sub-segmented into class I, class II, and class III. Increased spending by the pharmaceutical companies on R&D, rising prevalence of chronic disease, and an increasing number of CROs are some major factors positively affecting the market growth.

Regional Insights: Healthcare Contract Development And Manufacturing Organization Market

North America held the largest share of the healthcare CDMO market in 2019 and is expected to continue its dominance over the forecast period. Change in lifestyle habits such as smoking, lack of physical activity, and alcohol consumption is leading to growth in the number of chronic diseases in the region. Due to this, the demand for pharmaceutical products is increasing, which is inducing various pharmaceutical companies to outsource the manufacturing of drugs to CDMOs. It is one of the major factors responsible for the market growth of CDMO in North America.

Asia Pacific is expected to witness the fastest CAGR of 8.9 % over the forecast period. Asia Pacific continues to be leading the market in healthcare contract development & manufacturing organization due to low manufacturing costs as compared to North America and Europe. China and India are the major suppliers of API manufacturing services in the region.

Healthcare Contract Development And Manufacturing Organization Market Share Insights
The market is highly competitive in nature with the presence of some major market players that include

 	
Catalent Inc.
 	
Lonza Group Ltd.
 	
Recipharm AB
 	
Siegfried Holding AG
 	
Thermo Fisher Scientific Inc.
 	
Covance Inc.
 	
Jabil
 	
Sanmina Corporation
 	
IQVIA Holdings Inc.
 	
 Flex.

The key parameter affecting the competitive nature is the rapid adoption of advanced healthcare technology for improved healthcare. Also, to retain market share and diversify the product portfolio, major players are undertaking strategies such as mergers, acquisitions, and partnerships.
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Trusted Business Insights has segmented the global healthcare contract development and manufacturing organization market report on the basis of services and region:

Service Outlook (Revenue, USD Billion, 2016 - 2027)

 	
Contract Development
 	
Preclinical

Bioanalysis and DMPK studies

 	
Toxicology Testing

Other Preclinical Services

 	
Clinical
 	
Phase I
 	
Phase II
 	
Phase III
 	
Phase IV
 	
Laboratory Services
 	
 Bioanalytical Services
 	
 Analytical Services

Contract Manufacturing

 	
API/Bulk Drugs

Finished Dose Formulations

 	
Medical Device
 	
 Class I
 	
 Class II
 	
 Class III